Molecular genetic diagnosis of leukemias and lymphomas;Molekylærgenetisk diagnostikk av leukemier og lymfomer

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 16, 1998, Pages 2511-2518

  Heim, Sverre ^a   Smeland, Erlend B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

B LYMPHOCYTE; CHROMOSOME ABERRATION; GENE TRANSLOCATION; GENETIC PROCEDURES; GENETIC SCREENING; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA; LYMPHOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; REVIEW; T LYMPHOCYTE;

B-LYMPHOCYTES; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; GENETIC SCREENING; GENETIC TECHNIQUES; HUMANS; IMMUNOGLOBULINS; LEUKEMIA; LYMPHOMA; ONCOGENES; T-LYMPHOCYTES; TRANSLOCATION, GENETIC;

EID: 0032550855     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Heim S, Mitelman F. Cancer cytogenetics. Chromosomal and molecular genetic aberrations of tumor cells. 2. utg. New York: Wiley-Liss, 1995.
2. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997; 15: 417-74.
3. Mitelman F, Heim S. Quantitative acute leukemia cytogenetics. Genes Chromosom Cancer 1992; 5: 57-66.
4. Caliguri MA, Strout MP, Gilliland DG. Molecular biology of acute myeloid leukemia. Semin Oncol 1997; 24: 32-44.
5. Lust JA. Molecular genetics and lymphoproliferative disorders. L Clin Lab Analysis 1996; 10: 359-67.
6. Medeiros LJ, Weiss L. The utility of the polymerase chain reaction as a screening method for the detection of antigen receptor gene rearrangements. Hum Pathol 1994; 25: 1261-3.
7. Segal GH, Jorgensen T, Scott M, Braylan PC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis. Hum Pathol 1994; 25: 1276-82.
8. Svejgaard A, Madsen HO, Nyvold C, Ryder LP, Schmiegelow K. Molekylærbiologisk diagnostik og monitorering ved akut lymfoblastær leukæmi og ved non-Hodgkin-lymfom. Ugeskr Læger 1996; 158: 7101-2.
9. Veronese ML, Schichman SA, Croce CM. Molecular diagnosis of lymphoma. Curr Opin Oncol 1996; 8: 346-52.
10. Drexler HG, Borkhardt A, Janssen JWG. Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. Leuk Lymphoma 1995; 19: 359-80.
11. Thandla S, Aplan PD. Molecular biology of acute lymphocytic leukemia. Semin Oncol 1997; 24: 45-56.
12. Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991; 6: 2271-6.
13. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995; 85: 2528-36.
14. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 1995; 86: 3118-22.
15. Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R et al. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet 1994; 343: 196-200.
16. Nizet Y, Martiat P, Vaerman JL, Philippe M, Wildmann C, Staelens JP et al. Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br J Haematol 1991; 79: 205-10.
17. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 1997; 336: 317-23.
18. Nucifora G, Larson RA, Rowley JD. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82: 712-5.
19. Greaves M. Silence of the leukemic clone. N Engl J Med 1997; 336: 367-9.
20. Heim S. Is cancer cytogenetics reducible to the molecular genetics of cancer cells? Genes Chromosom Cancer 1992; 5: 188-96.
21. Aarset H, Skarsvåg S, Haugen O. Lavgradig non-Hodgkins lymfomer av B-celletype. Tidsskr Nor Lægeforen 1998; 118: 411-5.
22. Forestier E, Gustafsson G, von Heideman A, Heim S, Hernell O, Nordenson I et al. Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986-91. Acta Paediatr 1997; 86: 819-25.
23. Mrozek K, Heinonen K, de la Chapelle A, Bloomfield CD. Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 1997; 24: 17-31.
24. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990; 323: 720-4.